期刊文献+

抑瘤素M在糖尿病小鼠肾组织中的表达 被引量:1

Expression of oncostatin M in kidney of diabetic mice
下载PDF
导出
摘要 目的探讨抑瘤素M(oncostatin M,OSM)在糖尿病小鼠肾组织中的表达。方法腹腔注射链脲佐菌素(Streptozotocin,STZ;150 mg/kg)诱发糖尿病小鼠模型,分别于成模后4、8和12周收集肾组织标本进行以下检测:免疫组织化学和酶联免疫吸附实验检测肾组织中OSM的表达;马松染色观察肾小管间质纤维化程度。结果与对照组相比,糖尿病小鼠肾组织中OSM的表达明显高于对照组增多,且其表达与肾小管间质纤维化程度呈正相关(r=0.946,P<0.01)。结论 OSM在糖尿病小鼠肾组织中的表达升高并可能参与了肾小管间质纤维化的进展。 [Objective ] To investigate the expression of oncostatin M (OSM) in the renal cortex of diabetic mice. [Method] Male CD-1 mice were randomly divid~~d into two groups: control group (N) and diabetic group (DM). The mice of diabetic group received a single intraperitoneal injection of STZ at a dose of 150 mg/kg body weight. The expression of OSM was detected by the methods c f immunohistochemistry and ELISA. Masson staining was used for calculating the renal interstitial fibrosis area(the percentage of the blue stain to the whole area). [ Results ] Compared with the control mice, the OSM expression increased in mice with diabetes. The expression level of OSM is positively correlated with the degree of tubulointerstitial fibrosis (r =0.946, P 〈0.01). [ Conclusion] In diabetic mice, the OSM expression is increased, which maybe involved in the progression of tubulointerstitial fibrosis.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2014年第22期1-4,共4页 China Journal of Modern Medicine
基金 教育部高等学校博士学科点专项科研基金(No:2013132320001) 河北省卫生厅医学科学研究重点课题(No:20110081) 河北省教育厅科学研究项目(No:2011168)
关键词 糖尿病肾病 抑瘤素M 肾小管间质病变 diabetic nephropathy oncostatin M tubulointerstitial fibrosis
  • 相关文献

参考文献14

  • 1K ATHERINE R, TUTTLE KR. [+inking metabolism and immunology: diabetic nephropathy is an inflammation disease[J]. J Am See Nephrol, 2005, 16(6): 1537-1538.
  • 2LEASK A, ABRAHAM DJ. TGF-B signaling and the fibrotic response[J]. FASEB J, 2004. 18(7): 816-827.
  • 3MELDRUM KK, MISSERt R, METCALFE P, et M. TNF- neutralization ameliorates obstruction-induced renal fibrosis and dysfunction [J]. Am J Physiol Re:llatory Integrative Comp Physiol, 2007, 292(4): R1456-R1464.
  • 4NIGHTINGALE J, PATEL S, SUZUKI N, et at. Oneostatin M, a cytokine released by activated mononuclear cells, induces epithelial cell-myofibroblast transdifferentiation via jak/sta! pathway ac!ivation[J], J Am Soc Nephml, 2004, 15(1): 21-32.
  • 5POLLACK V, SARK?ZI R, BANKI Z, et at. OncostatinM-induced effects on EMT in human proximal tubular ceils: differential role of ERK signaling [J]. Am J Physial Renal Physiol, 2007, 293(5): F1714-F1726.
  • 6MORA C, NAVARRO JF. Inflammation and diabetic nephropathy [J]. Curr Diabetics, 2006, 6(6): 463-468.
  • 7NORONHA IL, FUJIHARA CK, ZATZ R. The inflammatory component in progressive renal disease-are interventions possible [J]. Nephrol Dial Transplant, 2002, 17(3): 363-368.
  • 8CHOW FY, NIKOLIC-PATERSON D J, OZOLS E, et al. Monecyte ehe-moattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice[J]. Kidney Int, 2006, 69(1): 73-80. .
  • 9CHOW FY, NIKOLIC-PATERSON D J, OZOLS E, et al. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice [J]. J Am Soc Nephrol, 2005, 16(6): 1711-1722.
  • 10NAKAGAWA T, Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for theparadoxical effects of VEGF in renal disease [J]. Am J Physiol Renal PhysM, 2007, 292(6): F1665-F1672.

同被引文献9

  • 1Richards C D. The enigmatic cytokine oncostatin m and roles in disease[ J]. ISRN Inflamm, 2013,2013:512103.
  • 2Sarkazi R, Hauser C, Noppert S J, et al. Oncostatin M is a novel inhibitor of TGF-β1-induced matrieellular protein expression [ J]. Am J Physiol Renal Physio, 2011,301 (5) : F1014 - 25.
  • 3Sarkiszi R, Flueher K, Haller V M, et al. Oncostatin Minhibits TGF-β1-induced CTGF expression via STAT3 in human proximal tubular cells [ J ]. Biochem Biophys Res Commtm, 2012,424 (4) : 801 -6.
  • 4Pastuschek J, Poetzseh J, Morales-Prieto D M, et al. Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulo- sa cell line COV434 [ J ]. J Reprod Immunol, 2015,108 (4) :48 - 55.
  • 5Natesh K, Bhosale D, Desai A, et al. Oncostatin-M differentially regulates mescnchymal and proneural signature genes in gliomas via STAT3 signaling [ J ]. Neoplasia, 2015,17 ( 2 ) : 225 - 37.
  • 6Nightingale J, Patel S, Suzuki N, et al. Oncostatin M, a cytokine released by activated mononuclear ceils, induces epithelial cell- myofibroblast transdifferentiation via Jak/Stat pathway activation [J]. J Am Soc Nephrol, 2004,15(1) :21 -32.
  • 7Pollack V, Sarkazi R, Banki Z, et al. Oncostatin M-induced effects on EMT in human proximal tubular cells : differential role of ERK signaling[ J]. Am J Physiol Renal Physiol, 2007,293 (5) : F1714 - 26.
  • 8Elbjeirami W M, Truong L D, Tawil A, et al. Early differential expression of oncostatin M in obstructive nephropathy [ J ]. J Inter- feron Cytokine Res, 2010,30(7 ) :513 - 23.
  • 9Schindler C, Levy D E, Decker T. JAK-STAT signaling: from in- terferons to cytokines[ J]. J Biol Chem, 2007,282(28) :20059 - 63.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部